Global Platelet Aggregation Devices Market 2024-2031

Description

List of Tables

Global Platelet Aggregation Devices Market Size, Share & Trends Analysis Report by Product (Optical Platelet Aggregometers, Impedance Platelet Aggregometers, Photometric Platelet Aggregometers, Whole Blood Platelet Aggregation Devices, Platelet Aggregation Reagents, and Others), and by End-User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others) Forecast Period (2024-2031)

Global platelet aggregation devices market is anticipated to grow at a significant CAGR of 17.9% during the forecast period (2024-2031). The market's growth is attributed to growing acceptability and awareness, in addition to rising demand for platelet screening programs and technology improvements. According to the BCM, in September 2023,the latest advancements in the clinical application of p-EVs, HPLs, and allogeneic platelets in cell therapy, regenerative medicine, and targeted drug delivery systems are examined in depth in this analysis.

Market Dynamics

Increasing prevalence of heart disease, strokes, and related disorders

The rising prevalence of cardiovascular and peripheral vascular disorders calls for ongoing research to develop diagnostic and treatment approaches, with platelet aggregation devices providing an essential component. According to theBritish Heart Foundation, in January 2024Heart and circulatory diseases continue to be a significant global health concern, affecting approximately 1 in 13 people globally. In 2019, there were an estimated 290 million women and 260 million men living with these conditions. The prevalence of these diseases has been steadily increasing over the years, with the global number of cases. Additionally, heart disease, peripheral arterial disease, stroke, and atrial fibrillation are among the most common cardiovascular conditions, collectively impacting millions of individuals. Tragically, heart and circulatory diseases remain the leading cause of death globally, accounting for approximately 1 in 3 fatalities, or 20.5 million fatalities in 2021.

Market Segmentation

Our in-depth analysis of the global platelet aggregation devicesmarket includes the following segments by product, end user:

Based on product, the market is sub-segmented into optical platelet aggregometers, impedance platelet aggregometers, photometric platelet aggregometers, whole blood platelet aggregation devices, platelet aggregation reagents, and others.
Based on end-user, the market is bifurcated into hospitals, diagnostic laboratories, research and academic institutes, and others.

Hospital is Projected to Emerge as the Largest Segment

Based on the end user, the platelet aggregation devices market is sub-segmented into hospitals, diagnostic laboratories, research and academic institutes, and others. Among these, the hospital sub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes the increasing demand for accurate diagnoses and patient care in hospitals.

Impedance Platelet Aggregometers Holds Considerable Market Share Based on Product

The increasing development in the measurement of platelet aggregation in whole-blood samples utilizing impedance-based detection techniques. According to the National Institute of Health (gov.), in October 2019, in the present study, several platelet activators were utilized to measure platelet aggregation utilizing impedance aggregometry using the multiplate equipment. Impedance aggregometry using whole-blood samples allowed for rapidly results during surgery, in contrast to classical Bornaggregometry, that demands patience and is accessible in specialized facilities.

Regional Outlook

The global platelet aggregation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific to Exhibit Fastest CAGR

The growing demand for clinical uses corresponds with the common surgical techniques performed by surgeons in India.As a result there is growing demand for clinical applications and accordingly companies are launching new and innovative products for surgeries to meet this growing demands.For instance, inFebruary 2022FuturaSurgicarePvt. Ltd. has introduced Hemostatic products under the brand Hemostax, an absorbable hemostat designed to aid surgeons in controlling bleeding. It is suitable for various surgeries, including gynecologic, oncologic, cardiovascular, and general procedures.

North America Holds Major Market Share

Among all the regions, North America holds a significant share owing to the he significance of advancements in platelet aggregation device technology, including sensor sensitivity, automation, and data analytics.

According to the Anesthesiology, in September 2023,the study included a total of 50 patients, with 35.0% undergoing isolated coronary artery bypass graft, 52.0% valve surgery, and 12.0% aortic root surgery. The median red blood cell recovery per cycle was 86.1%, with a posttreatment hematocrit of 41.8%. The device showed high removal ratios for heparin and free hemoglobin, at 98.9% and 94.6% respectively.

Market Players Outlook

The major companies serving the global platelet aggregation devices market includeAggreDyne, Inc.Medtronic Pvt. Ltd.,SiemensHealthineers co.,Sysmex Corp. Werfen, S.A. and others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in January 2023 Precision BioLogic Inc., launched new CRYOcheck Chromogenic Factor IX assay. The CRYOcheck Chromogenic Factor IX is a FDA-cleared assay used in clinical labs to identify factor IX deficiency in human plasma, aiding in hemophilia B management.

The Report Covers:

Market value data analysis of 2023and forecast to 2031.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global platelet aggregation devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2028160

1.Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1.Research Methods and Tools
1.2.Market Breakdown
- 1.2.1.By Segments
- 1.2.2.By Region

2.Market Overview and Insights

2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
- 2.2.1.Key Findings
- 2.2.2.Recommendations
- 2.2.3.Conclusion

3.Competitive Landscape

3.1.Key Company Analysis
3.2.At F. Hoffmann-La Roche Ltd.
- 3.2.1.Overview
- 3.2.2.Financial Analysis
- 3.2.3.SWOT Analysis
- 3.2.4.Recent Developments
3.3.Bio/Data Corp.
- 3.3.1.Overview
- 3.3.2.Financial Analysis
- 3.3.3.SWOT Analysis
- 3.3.4.Recent Developments
3.4.Greiner Bio-One International GmbH
- 3.4.1.Overview
- 3.4.2.Financial Analysis
- 3.4.3.SWOT Analysis
- 3.4.4.Recent Developments
3.5.Key Strategy Analysis

4.Market Segmentation

4.1.Global Platelet Aggregation Devices Market by Product
- 4.1.1.Optical Platelet Aggregometers
- 4.1.2.Impedance Platelet Aggregometers
- 4.1.3.Photometric Platelet Aggregometers
- 4.1.4.Whole Blood Platelet Aggregation Devices
- 4.1.5.Platelet Aggregation Reagents
- 4.1.6.Others(Multiple Electrode Aggregometry (MEA) Devices, and Light Transmission Aggregometers)
4.2.Global Platelet Aggregation Devices Market by End-User
- 4.2.1.Hospitals
- 4.2.2.Diagnostic Laboratories
- 4.2.3.Research and Academic Institutes
- 4.2.4.Others (Blood Banks and Pharmaceutical &Biotechnology Companies)

5.Regional Analysis

5.1.North America
- 5.1.1.United States
- 5.1.2.Canada
5.2.Europe
- 5.2.1.UK
- 5.2.2.Germany
- 5.2.3.Italy
- 5.2.4.Spain
- 5.2.5.France
- 5.2.6.Rest of Europe
5.3.Asia-Pacific
- 5.3.1.China
- 5.3.2.India
- 5.3.3.Japan
- 5.3.4.South Korea
- 5.3.5.Rest of Asia-Pacific
5.4.Rest of the World

6.Company Profiles

6.1.AggreDyne, Inc.
6.2.Chrono-Log Corp.
6.3.Drucker Diagnostics
6.4.Grifols, S.A.
6.5.Haemonetics
6.6.HeamochromDiagnostica GmbH
6.7.Hetzner Online GmbH
6.8.Matis Medical, Inc.
6.9.Medtronic Pvt. Ltd.
6.10.Perlong Medical Equipment Co., Ltd.
6.11.SENTINEL CH. SpA
6.12.Siemens Healthineers co.
6.13.Sienco, Inc.
6.14.Sysmex Corp.
6.15.Tem Group
6.16.Werfen, S.A.